CFLT250117C28000
- 0.06
- 0.000.00%
Confluent Newsroom
Confluent Health Expands C-Suite Leadership
Express News | Confluent Inc : Mizuho Cuts Target Price to $32 From $35
Morgan Stanley: The momentum of generative AI will be strong in 2025, listing MongoDB (MDB.US) as a "preferred" choice.
Due to the momentum of generative AI in 2025, MongoDB has been listed as a "preferred" option by Morgan Stanley.
MongoDB Added as 'Top Pick' Due to Generative-AI in 2025: Morgan Stanley
Morgan Stanley Maintains Confluent(CFLT.US) With Hold Rating, Maintains Target Price $30
Top Gap Ups and Downs on Thursday: TSM, TM, AMAT and More
Confluent Shares Are Trading Lower After Morgan Stanley Downgraded the Stock From Overweight to Equal-Weight and Lowered Its Price Target From $33 to $30.
Confluent Slides on Back of Morgan Stanley Downgrade
Confluent Cut to Equal-Weight From Overweight by Morgan Stanley
Morgan Stanley Downgrades Confluent(CFLT.US) to Hold Rating, Cuts Target Price to $30
Confluent's Hold Rating: Balancing AI Potential With Adoption Challenges and Revenue Risks
Unusual Options Activity: PAA, CFLT and Others Attract Market Bets, PAA V/OI Ratio Reaches 163.9
Deutsche Bank Maintains Confluent(CFLT.US) With Buy Rating, Raises Target Price to $34
Confluent Price Target Raised to $34 From $30 at Deutsche Bank
Unusual Options Activity: EXE, NVDA and Others Attract Market Bets, EXE V/OI Ratio Reaches 282.5
Atlassian, Datadog See Rating Changes at Truist, Firm Highlights Sector Outlook
What Analysts Are Saying About Confluent Stock
Evercore's AI Enablers, Adopters and Adapters: CRM, MU, CI, EQT and More
Piper Sandler Maintains Overweight on Confluent, Raises Price Target to $35
Confluent to Announce Fourth Quarter and Fiscal Year 2024 Financial Results on February 11, 2025